Expression of the hormonal receptors for Estrogen (ER) and Progesterone (PR) as well as the Human epidermal growth factor receptor 2 (HER-2) are used for risk stratification and treatment selection for patients with breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.